Zostavax vaccine and immunocompromised individuals fact sheet
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This fact sheet is for health professionals.
Administration of Zostavax to people who are immunocompromised is associated with risk of disseminated disease from the vaccine virus. As a result is is recommended that Zostavax not be administered to patients who are immunocompromised.
This fact sheet provides:
- contraindication details
- a guide to safe doses of immunosuppressive therapy for Zostavax administration
- immunisation contact details
- links to more information.